PHS
AR icon

PFM Health Sciences’s Antero Resources AR Stock Holding History

PFM Health Sciences’s Portfolio AR Stock Details AR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,753,495
Closed -$45.6M – 87
2016
Q2 		$45.6M Buy
+1,753,495
New +$47.8M 1.37% 32

Other funds holding AR

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
FPR Partners San Francisco, California $579M AUM 26.76% 1-Year Est. Return
YEPV
Yorktown Energy Partners VIII New York $52.9M AUM 30% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
YEPV
Yorktown Energy Partners VII New York $23.4M AUM 17.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PFM Health Sciences's AR Position: Q3 2016 in Review

PFM Health Sciences sold out of Antero Resources (AR) in Q3 2016, closing a stake of 1,753,495 shares — an estimated $45.6M sold.

PFM Health Sciences first reported a position in AR in Q2 2016 and held it in 1 quarter. The position peaked at $45.6M in Q2 2016. 311 funds tracked by Wall St. Rank hold AR as of Q3 2016.

  • PFM Health Sciences reported no remaining Antero Resources position as of Q3 2016 after selling out during the quarter.
  • PFM Health Sciences sold 1,753,495 Antero Resources shares in Q3 2016, an estimated $45.6M.
  • PFM Health Sciences first reported a position in Antero Resources in Q2 2016 and held it in 1 quarter.
  • PFM Health Sciences's Antero Resources position peaked at $45.6M in Q2 2016.
  • 311 funds tracked by Wall St. Rank held Antero Resources as of Q3 2016.

Based on PFM Health Sciences's 13F filing for Q3 2016, filed 14 Nov 2016.